KFF December 19, 2024
Delaney Tevis, Matt McGough, Juliette Cubanski, Cynthia Cox

This analysis for the KFF-Peterson Health System Tracker compares the Medicare’s first-ever negotiated drug prices under a new process created by the Inflation Reduction Act of 2022 to current U.S. list prices, prices negotiated by the Department of Veterans Affairs (VA), and prices in 11 countries of similar size and wealth.

It finds that Medicare’s negotiated prices for 10 high-expenditure prescription drugs are lower...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech, Survey / Study, Trends
Related Articles:
CMS Launches New Program for Mental Health, OUD Treatment
Telehealth groups call for urgent action as Medicare flexibility deadline looms
Innovating Without Compromising Integration: Considerations For Medicare
How the Federal Government Could Push People Toward Medicare Advantage – And Replace Traditional Medicare
Changing Medicare Payment to Strengthen Primary Care

Share This Article